SU‐E‐T‐779: Adaptive RapidArc Treatment Planning for Esophageal Cancers Using Cone Beam Computed Tomography
Purpose: To assess the potential of cone beam CT (CBCT) derived adaptive RapidArc treatment for esophageal cancers in reducing the dose to organs at risk (OAR). Methods: Five patients with esophageal cancer were CT scanned in free breathing pattern. The PTV is generated by adding a 3D margin of 1 cm...
Gespeichert in:
Veröffentlicht in: | Medical Physics 2011-06, Vol.38 (6), p.3670-3670 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose: To assess the potential of cone beam CT (CBCT) derived adaptive RapidArc treatment for esophageal cancers in reducing the dose to organs at risk (OAR). Methods: Five patients with esophageal cancer were CT scanned in free breathing pattern. The PTV is generated by adding a 3D margin of 1 cm to the CTV as per ICRU 62 recommendations. The double arc RapidArc plan (Clin_RA) was generated for the PTV. Patients were setup using lasers and tattoos and kV‐CBCT scan was acquired daily during first week of therapy, then weekly. Setup errors > 5 mm only were corrected. These images were exported to the Eclipse TPS. The adaptive CTV which includes tumor and involved nodes was delineated in each CBCT image set for the length of PTV. The composite CTV from first week CBCTs was generated using Boolean union operator and 5 mm margin was added circumferentially to generate adaptive PTV (PTV1). Adaptive RapidArc plan (Adap_RA) was generated. NTCP and DVH of the OARs of the two plans were compared. Similarly, PTV2 is generated from weekly CBCTs. PTV2 was evaluated for the coverage of 95% isodose of Adap_RA plan. Results: The PTV1 and PTV2 volumes covered by 95% isodose in adaptive plans were 93.16±1.8% and 94.66±1.45% respectively. The lung V10Gy, V20Gy and mean dose in Adap_RA plan was reduced by 17.36% (p=0.001), 34.86% (p=0.002) and 16.74% (p |
---|---|
ISSN: | 0094-2405 2473-4209 |
DOI: | 10.1118/1.3612743 |